| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan.
|
Eur J Radiol
|
2006
|
3.39
|
|
2
|
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.
|
J Clin Oncol
|
2008
|
3.27
|
|
3
|
Nationwide survey on complementary and alternative medicine in cancer patients in Japan.
|
J Clin Oncol
|
2005
|
2.87
|
|
4
|
Effects of a programme of interventions on regional comprehensive palliative care for patients with cancer: a mixed-methods study.
|
Lancet Oncol
|
2013
|
2.34
|
|
5
|
Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project.
|
J Clin Oncol
|
2002
|
2.18
|
|
6
|
A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
|
J Thorac Oncol
|
2008
|
2.01
|
|
7
|
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
|
J Clin Oncol
|
2006
|
1.88
|
|
8
|
Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan.
|
Cancer
|
2003
|
1.82
|
|
9
|
Focal ground-glass opacity detected by low-dose helical CT.
|
Chest
|
2002
|
1.79
|
|
10
|
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin.
|
Cancer Sci
|
2010
|
1.72
|
|
11
|
Virus-associated hemophagocytic syndrome in an international traveler as a differential diagnosis of SARS.
|
Intern Med
|
2005
|
1.54
|
|
12
|
Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade.
|
J Thorac Oncol
|
2011
|
1.53
|
|
13
|
A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer.
|
J Thorac Oncol
|
2008
|
1.53
|
|
14
|
Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
|
Lung Cancer
|
2006
|
1.43
|
|
15
|
Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
|
J Thorac Oncol
|
2009
|
1.38
|
|
16
|
Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.
|
Lung Cancer
|
2008
|
1.27
|
|
17
|
Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography.
|
Ann Thorac Surg
|
2003
|
1.20
|
|
18
|
Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database.
|
J Thorac Oncol
|
2009
|
1.19
|
|
19
|
Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer.
|
J Comput Assist Tomogr
|
2004
|
1.13
|
|
20
|
Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
|
J Thorac Oncol
|
2010
|
1.13
|
|
21
|
Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
|
Clin Cancer Res
|
2002
|
1.10
|
|
22
|
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group.
|
Breast Cancer Res Treat
|
2009
|
1.05
|
|
23
|
Providing palliative care for cancer patients: the views and exposure of community general practitioners and district nurses in Japan.
|
J Pain Symptom Manage
|
2011
|
1.03
|
|
24
|
Preferred place of care and place of death of the general public and cancer patients in Japan.
|
Support Care Cancer
|
2012
|
1.03
|
|
25
|
Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
|
J Thorac Oncol
|
2012
|
1.02
|
|
26
|
Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.
|
Anticancer Res
|
2010
|
0.99
|
|
27
|
Cancer patients' reluctance to disclose their emotional distress to their physicians: a study of Japanese patients with lung cancer.
|
Psychooncology
|
2008
|
0.99
|
|
28
|
Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
|
J Thorac Oncol
|
2010
|
0.96
|
|
29
|
Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
|
Lung Cancer
|
2007
|
0.96
|
|
30
|
Palliative care in Japan: current status and a nationwide challenge to improve palliative care by the Cancer Control Act and the Outreach Palliative Care Trial of Integrated Regional Model (OPTIM) study.
|
Am J Hosp Palliat Care
|
2008
|
0.96
|
|
31
|
Quantitative classification based on CT histogram analysis of non-small cell lung cancer: correlation with histopathological characteristics and recurrence-free survival.
|
Med Phys
|
2012
|
0.95
|
|
32
|
Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
|
J Clin Oncol
|
2006
|
0.95
|
|
33
|
Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database.
|
J Thorac Oncol
|
2013
|
0.94
|
|
34
|
Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer.
|
J Thorac Oncol
|
2008
|
0.93
|
|
35
|
Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.
|
Lung Cancer
|
2010
|
0.92
|
|
36
|
Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
|
Cancer
|
2002
|
0.92
|
|
37
|
Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient.
|
Pathol Int
|
2009
|
0.91
|
|
38
|
Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004.
|
J Thorac Oncol
|
2014
|
0.90
|
|
39
|
Pain intensity, quality of life, quality of palliative care, and satisfaction in outpatients with metastatic or recurrent cancer: a Japanese, nationwide, region-based, multicenter survey.
|
J Pain Symptom Manage
|
2012
|
0.89
|
|
40
|
A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy.
|
Jpn J Clin Oncol
|
2002
|
0.89
|
|
41
|
Promising new treatment schedule for gefitinib responders after severe hepatotoxicity with daily administration.
|
J Clin Oncol
|
2006
|
0.89
|
|
42
|
Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.
|
Eur J Cardiothorac Surg
|
2013
|
0.89
|
|
43
|
Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.
|
Jpn J Clin Oncol
|
2003
|
0.89
|
|
44
|
Hypercalcemia-leukocytosis syndrome associated with lung cancer.
|
Lung Cancer
|
2004
|
0.88
|
|
45
|
Modern surgical results of lung cancer involving neighboring structures: a retrospective analysis of 531 pT3 cases in a Japanese Lung Cancer Registry Study.
|
J Thorac Cardiovasc Surg
|
2012
|
0.87
|
|
46
|
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
|
Anticancer Res
|
2008
|
0.86
|
|
47
|
A computer-aided diagnosis (CAD) system in lung cancer screening with computed tomography.
|
Anticancer Res
|
2005
|
0.85
|
|
48
|
Irreversible imatinib-induced pneumonitis following long-term imatinib administration.
|
Intern Med
|
2007
|
0.85
|
|
49
|
Improvements in surgical results for lung cancer from 1989 to 1999 in Japan.
|
J Thorac Oncol
|
2009
|
0.85
|
|
50
|
Measurement of localized ground-glass attenuation on thin-section computed tomography images: correlation with the progression of bronchioloalveolar carcinoma of the lung.
|
Invest Radiol
|
2002
|
0.84
|
|
51
|
Preparation of purified, sterilized, and stable adenovirus vectors using albumin.
|
J Virol Methods
|
2002
|
0.84
|
|
52
|
[Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004].
|
Nihon Kokyuki Gakkai Zasshi
|
2011
|
0.84
|
|
53
|
A region-based palliative care intervention trial using the mixed-method approach: Japan OPTIM study.
|
BMC Palliat Care
|
2012
|
0.84
|
|
54
|
Public awareness, knowledge of availability, and readiness for cancer palliative care services: a population-based survey across four regions in Japan.
|
J Palliat Med
|
2011
|
0.82
|
|
55
|
Gefitinib-induced lung injury successfully treated with high-dose corticosteroids.
|
Respirology
|
2006
|
0.82
|
|
56
|
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip system.
|
Anticancer Res
|
2005
|
0.81
|
|
57
|
Mental health literacy in Japanese cancer patients: ability to recognize depression and preferences of treatments-comparison with Japanese lay public.
|
Psychooncology
|
2007
|
0.81
|
|
58
|
Influence of slice thickness on diagnoses of pulmonary nodules using low-dose CT: potential dependence of detection and diagnostic agreement on features and location of nodule.
|
Acad Radiol
|
2011
|
0.80
|
|
59
|
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
|
J Thorac Oncol
|
2011
|
0.80
|
|
60
|
Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers.
|
J Thorac Oncol
|
2008
|
0.80
|
|
61
|
Patient-perceived usefulness and practical obstacles of patient-held records for cancer patients in Japan: OPTIM study.
|
Palliat Med
|
2011
|
0.80
|
|
62
|
Pulmonary adenocarcinoma associated with SAPHO syndrome difficult to differentiate from multiple bone metastasis.
|
Intern Med
|
2006
|
0.79
|
|
63
|
Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.
|
J Thorac Oncol
|
2014
|
0.79
|
|
64
|
Introduction of endobronchial ultrasonography (EBUS) in bronchoscopy clearly reduces fluoroscopy time: comparison of 147 cases in groups before and after EBUS introduction.
|
Jpn J Clin Oncol
|
2011
|
0.79
|
|
65
|
Patient-perceived barriers to the psychological care of Japanese patients with lung cancer.
|
Jpn J Clin Oncol
|
2008
|
0.79
|
|
66
|
Analysis of incomplete quality of life data in advanced stage cancer: a practical application of multiple imputation.
|
Qual Life Res
|
2005
|
0.79
|
|
67
|
The adenocarcinoma-specific stage shift in the Anti-lung Cancer Association project: significance of repeated screening for lung cancer for more than 5 years with low-dose helical computed tomography in a high-risk cohort.
|
Lung Cancer
|
2009
|
0.78
|
|
68
|
[A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients].
|
Nihon Igaku Hoshasen Gakkai Zasshi
|
2005
|
0.78
|
|
69
|
[Problems and potential solutions of regional palliative care: a trial of the multiregional and multidisciplinary conference in the OPTIM study].
|
Gan To Kagaku Ryoho
|
2011
|
0.78
|
|
70
|
Exploring the perceived changes and the reasons why expected outcomes were not obtained in individual levels in a successful regional palliative care intervention trial: an analysis for interpretations.
|
Support Care Cancer
|
2013
|
0.78
|
|
71
|
Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502.
|
Lung Cancer
|
2010
|
0.77
|
|
72
|
Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
|
Jpn J Clin Oncol
|
2006
|
0.77
|
|
73
|
A population-based survey on perceptions of opioid treatment and palliative care units: OPTIM study.
|
Am J Hosp Palliat Care
|
2013
|
0.77
|
|
74
|
The need for measures to prevent "solitary deaths" after large earthquakes - based on current conditions following the Great Hanshin-Awaji Earthquake.
|
J Forensic Leg Med
|
2008
|
0.77
|
|
75
|
Anemia affects the quality of life of Japanese cancer patients.
|
Tokai J Exp Clin Med
|
2013
|
0.77
|
|
76
|
Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category?
|
J Thorac Oncol
|
2013
|
0.77
|
|
77
|
Regional medical professionals' confidence in providing palliative care, associated difficulties and availability of specialized palliative care services in Japan.
|
Jpn J Clin Oncol
|
2014
|
0.77
|
|
78
|
A scale for measuring feelings of support and security regarding cancer care in a region of Japan: a potential new endpoint of cancer care.
|
J Pain Symptom Manage
|
2011
|
0.77
|
|
79
|
Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer.
|
Anticancer Res
|
2011
|
0.77
|
|
80
|
Does a regional comprehensive palliative care program improve pain in outpatient cancer patients?
|
Support Care Cancer
|
2014
|
0.76
|
|
81
|
Knowledge, beliefs, and concerns about opioids, palliative care, and homecare of advanced cancer patients: a nationwide survey in Japan.
|
Support Care Cancer
|
2011
|
0.76
|
|
82
|
Can epidermal growth factor receptor-fluorescent in situ hybridization predict clinical benefit from cetuximab treatment in patients with non-small-cell lung cancer?
|
J Clin Oncol
|
2008
|
0.76
|
|
83
|
[A Japanese lung cancer registry study at 2002].
|
Nihon Kokyuki Gakkai Zasshi
|
2010
|
0.76
|
|
84
|
Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer.
|
J Clin Epidemiol
|
2003
|
0.76
|
|
85
|
Previously reported lung cancer growth curves.
|
Chest
|
2010
|
0.75
|
|
86
|
Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study.
|
Int J Clin Oncol
|
2004
|
0.75
|
|
87
|
[The survey for anti-emetic guideline by using questioner].
|
Gan To Kagaku Ryoho
|
2015
|
0.75
|
|
88
|
Administrators' perspectives on end-of-life care for cancer patients in Japanese long-term care facilities.
|
Support Care Cancer
|
2009
|
0.75
|
|
89
|
Cancer patients' reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: a preliminary study.
|
Palliat Support Care
|
2009
|
0.75
|
|
90
|
An epidemiological analysis of drunk driving accidents in Kagawa Prefecture - comparison of 1997-2000 and 2003-2006.
|
J Forensic Leg Med
|
2008
|
0.75
|
|
91
|
Easier understanding of pleural indentation on computed tomography.
|
Intern Med
|
2007
|
0.75
|
|
92
|
[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
|
Gan To Kagaku Ryoho
|
2002
|
0.75
|
|
93
|
Symptom burden and achievement of good death of elderly cancer patients.
|
J Palliat Med
|
2014
|
0.75
|
|
94
|
Eosinophilic pleurisy induced by dantrolene.
|
Tokai J Exp Clin Med
|
2005
|
0.75
|
|
95
|
Phase I and pharmacokinetic study of KW-2170, a novel pyrazoloacridone compound, in patients with malignant tumors.
|
Cancer Chemother Pharmacol
|
2004
|
0.75
|
|
96
|
[Current status of palliative care in medical oncology].
|
Nihon Rinsho
|
2010
|
0.75
|
|
97
|
[The role to be played by the specialty of tumor chemotherapy: a discussion].
|
Nihon Naika Gakkai Zasshi
|
2009
|
0.75
|
|
98
|
Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
|
Anticancer Res
|
2004
|
0.75
|
|
99
|
Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.
|
J Thorac Oncol
|
2008
|
0.75
|
|
100
|
[Cancer screening].
|
Gan To Kagaku Ryoho
|
2005
|
0.75
|
|
101
|
Effects of bronchial intermittent constrictions on explosive flow during coughing in the dogs.
|
Jpn J Physiol
|
2003
|
0.75
|
|
102
|
Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale.
|
Support Care Cancer
|
2006
|
0.75
|
|
103
|
[Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer].
|
Gan To Kagaku Ryoho
|
2012
|
0.75
|
|
104
|
Impact of Fluticasone Diskhaler on health-related quality of life in asthmatic patients.
|
Tokai J Exp Clin Med
|
2002
|
0.75
|